other material
confidence high
sentiment neutral
materiality 0.65
Xeris Biopharma raises $30M in private placement with Armistice Capital
Xeris Biopharma Holdings, Inc.
- Gross proceeds of $30M from sale of 10.2M shares at $2.93/share (closing price Dec 31, 2021).
- Warrants to purchase up to 5.1M shares at $3.223/share, exercisable immediately for 5 years.
- Net proceeds to support operations, commercial products, clinical trials, working capital.
- Private placement expected to close Jan 3, 2022; resale registration statement to be filed.